Clinical Trials Logo

Osteitis clinical trials

View clinical trials related to Osteitis.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05103137 Completed - Clinical trials for Chronic Recurrent Multifocal Osteomyelitis

Post-transition Clinical and Socio-professional Future in Adult Patients With Recurrent Multifocal Chronic Osteitis

ESPERANTO
Start date: October 8, 2020
Phase:
Study type: Observational

Chronic Recurrent Multifocal Osteomyelitis (CRMO) is a rare autoinflammatory bone disease in children. Studies evaluating the quality of life of patients with CRMO are small and heterogeneous. A better understanding of the impact of the disease on the quality of life of adult patients with CRMO beginning in childhood would allow better long-term management of these patients. Our study aims are to assess the clinical and socio-professional outcomes of adult patients who started CRMO at pediatric age.

NCT ID: NCT04507009 Completed - Alveolar Osteitis Clinical Trials

Clinical Investigation of the Efficacy of CGF and Ozone in the Treatment of Alveolar Osteitis

Start date: August 1, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the efficacy of CGF and Ozone in the treatment of alveolitis and to develop a new treatment protocol that can enable a quick and effective solution of this clinical problem, which significantly affects patients' comfort of life.

NCT ID: NCT04313621 Completed - Clinical trials for Lower Limb Apophysitis (Severs, Osgood Schlatter, Sinding-Larsen Johansson)

Management of Lower Limb Apophysitis: A Cross-sectional Study on Long-term Impact on Health Status

Start date: April 8, 2021
Phase:
Study type: Observational [Patient Registry]

Lower limb apophysitis cause long-term pain, decrease in function, and can reduce or completely hinder participation in sports and physical activity, yet there is little knowledge on the long-term consequences for health. Our objective with this investigation is to capture self-reported health-status for all adults having been diagnosed with lower limb apophysitis in the period of 1977 to 2020 and compared these data with normative values for the background population. We are therefore conducting a national cross-sectional study based on data from the Danish National Patient Registry. In this protocol we describe, as detailed as possible, the planned methods.

NCT ID: NCT04151147 Completed - Alveolar Osteitis Clinical Trials

Effect of CGF on Frequency of Alveolar Osteitis Following Partially Erupted Mandibular Third Molar Surgery

Start date: January 2, 2018
Phase: N/A
Study type: Interventional

The aim of this prospective study was to assess the effectiveness of concentrated growth factors (CGFs) in preventing the development of alveolar osteitis (AO) after the extraction of partially-erupted mandibular third molars. This study was designed as a randomized controlled clinical trial. In each case, one socket received CGFs and the other served as a control. The predictor variable was the CGFs application and the sides were categorized as 'CGFs' and 'non-CGFs'. The outcome variable was the development of AO during the first postoperative week. Also, demographic variable included age and gender was noted.

NCT ID: NCT04091399 Completed - Alveolar Osteitis Clinical Trials

First-in-man Study of Adult Patients Suffered From Alveolar Osteitis Treated Using Stomatological Tamponade Contipro

Start date: September 11, 2015
Phase: Phase 2
Study type: Interventional

Alveolar Osteitis (AO) is a complication following extraction of a tooth. AO manifests by localized pain in and around the extraction site where the postoperative blood clot has been disintegrated. The aim of this study was to determinate if there are any concerns of use of a pharmacological drug composed of an octenidine and lyophilized hyaluronic acid in a treatment of AO. The tested drug is a sponge-like material composed solely of fully absorbable medicaments. It was designed to serve as non-toxic, slow-dissolving antiseptic which adheres to mucosa and so obturate the wound. The treatment was considered effective when the pain subsided to < 20mm VAS in < 8 days of treatment.

NCT ID: NCT03964818 Completed - Clinical trials for Pressure-related Osteitis

Pressure Sore-related Osteitis Treated by Flap Coverage and Short Antibiotic Regimen

SCAR
Start date: May 20, 2019
Phase:
Study type: Observational

Pressure ulcers associated with osteitis are frequent among patients with spinal cord injury (SCI), and optimal management is not well known. In a French referral center, debridement and flap coverage surgeries performed simultaneously are followed by a short antibiotic treatment targeting the bacteria involved. The aim of the study is to evaluate patient's outcome at Day 45 after surgery, and identify factors associated with failure.

NCT ID: NCT03960086 Completed - Sever's Disease Clinical Trials

Effectiveness of Custom-made Foot Orthoses vs Heel Lifts in Children With Calcaneal Apophysitis

Start date: June 12, 2019
Phase: N/A
Study type: Interventional

The study was a parallel-group, randomized controlled trial with concealed allocation, blinding of investigators and assessors and intention-to-treat analysis. It examined the effect of custom-made foot orthoses and heel lifts in children with calcaneal apophysitis. It was hypothesized that the primary outcome, pain relief, would be significantly improved with the custom-made orthosis compared to the heel lift.

NCT ID: NCT03641482 Completed - Alveolar Osteitis Clinical Trials

NBF Gingival Gel Application After Impacted Lower Third Molar Surgery

Start date: September 1, 2016
Phase: N/A
Study type: Interventional

Background: Alveolar osteitis is one of the most frequent complications after lower third molar extraction, and is usually accompanied by inflammation, pain and poor wound healing. Several local interventions have been used to reduce these complications with limited effectiveness. Purpose: To clinically evaluate the use of propolis extract, nanovitamin C and nanovitamin E gel for the prevention of surgical complications related to impacted lower third molar extraction. Methods: A randomized, triple-blind, split-mouth, pilot study is being performed in patients needing bilateral lower third molar extraction with similar surgical difficulty. Surgical extractions are randomly being performed and NBF gingival gel (TG) or placebo (PBG) are randomly being applied inside postextraction sockets by a blinded surgeon. The patients are being instructed to apply it 3 times/day in the surgical wound for 7 days. One month later, the contralateral wisdom tooth is being extracted and the opposite gel is being applied. Alveolar osteitis (AO) is being diagnosed following Blum's criteria. Swelling is being assessed by measuring the facial perimeter. Wound healing is being evaluated with a semi-quantitative scale as good, satisfactory or insufficient. Postoperative pain is being recorded using a visual analog scale (VAS) for 7 days. Analgesic pill intake is being recorded by each patient. Variables are being registered by a blinded researcher to 3M extractions at one, two, three and seven postoperative days.

NCT ID: NCT03494972 Completed - Clinical trials for Post-Operative Wound Infection

A Tetracycline Drain Reduces Alveolar Osteitis in Third Molar Surgery

Wisdomsteeth
Start date: January 2, 2016
Phase: N/A
Study type: Interventional

The aim of this study was to investigate the effect of an oxytetracycline impregnated gauze drain on the incidence of alveolar osteitis (AO) and postoperative pain during the first week after mandibular third molar surgery.

NCT ID: NCT02382809 Completed - Alveolar Osteitis Clinical Trials

Efficacy of 0.2 % Digluconate Chlorhexidine Mouthwash for Preventing Alveolar Osteitis After Third Molar Extraction

Start date: March 2015
Phase: Phase 4
Study type: Interventional

The purpose of this study is to demonstrate the efficacy of 0.2 % digluconate chlorhexidine mouthwash in the prevention of alveolar osteitis following third molar extraction and to evaluate the safety and local tolerability.